Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиSyros Pharmaceuticals Мультипликаторы 2011-2024 | SYRS
Мультипликаторы по годам Syros Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -0.5 | -0.1 | -0.5 | -3.7 | -3.0 | -4.9 | -2.8 | - | - | - | - | - |
P/S |
16.6 | 3.1 | 0.3 | 2.6 | 142.5 | 90.3 | 241.1 | 428.6 | - | - | - | - | - |
EPS |
-5.8 | -7.5 | -13.8 | -18.2 | -1.9 | -1.9 | -2.1 | -4.0 | -17.6 | -10.3 | - | - | - |
EV (Enterprise Value) |
25.9 млн | -121 млн | -84.2 млн | -135 млн | 312 млн | 163 млн | 246 млн | 88 млн | -26.3 млн | -59.1 млн | - | - | - |
EBITDA per Share |
-4.47 | -10.5 | -15.5 | -17.3 | -1.87 | -1.92 | -2.09 | -3.68 | - | - | - | - | - |
EV/EBITDA |
0.3 | -4.6 | -3.2 | -2.2 | -4.4 | -1.7 | - | - | - | - | - | ||
PEG |
-0.01 | -0.0 | 0.05 | 0.54 | -2.38 | -0.29 | -0.1 | 0.03 | - | - | - | - | - |
P/B |
1.0 | 0.2 | 0.0 | 0.2 | 3.6 | 2.4 | 4.1 | 1.7 | - | - | - | - | - |
P/CF |
-1.5 | -0.4 | -0.1 | -0.7 | -3.9 | -4.4 | -5.8 | -3.2 | - | - | - | - | - |
ROE % |
-987.72 | -74.10 | -101.57 | -92.81 | -95.27 | -79.25 | -82.68 | -59.23 | - | - | - | - | - |
ROA % |
-97.86 | -38.72 | -47.32 | -39.41 | -50.30 | -58.33 | -68.81 | -52.28 | - | - | - | - | - |
ROCE % |
-774.14 | -106.37 | -116.67 | -90.88 | -61.47 | -73.70 | -82.76 | -58.67 | - | - | - | - | - |
Current Ratio |
- | - | - | - | 4.9 | 5.2 | 5.9 | 8.9 | - | - | - | - | - |
DSO |
- | - | - | - | 3712.2 | - | - | 998.3 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Syros Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.43 | -1.3 | -0.85 | - | -3.21 | -5.4 | -3.99 | - | -4.14 | -0.36 | -0.23 | -0.62 | -0.43 | -0.38 | -0.39 | -0.46 | -0.47 | -0.47 | -0.49 | -0.54 | -0.47 | -0.43 | -0.48 | -0.58 | -0.53 | -0.52 | -0.49 | -0.47 | -0.65 | -5.42 | -5.15 | -5.14 | -4.51 | -4.16 | -3.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.17 | - | -3.98 | -5.08 | -4.12 | - | -3.95 | -0.39 | -0.33 | -0.6 | -0.37 | -0.34 | -0.38 | -0.47 | -0.44 | -0.46 | -0.49 | -0.55 | -0.45 | -0.42 | -0.48 | -0.59 | -0.49 | -0.5 | -0.48 | -0.47 | -0.6 | -4.48 | -4.31 | -4.61 | -3.76 | -3.36 | -2.72 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-205.79 | -118.63 | -180.29 | -174.66 | -199.20 | -200.32 | -106.46 | -51.34 | -84.61 | -152.83 | -228.29 | -311.56 | -303.21 | -305.66 | -308.12 | -310.58 | -308.61 | -292.66 | -276.72 | -260.77 | -261.25 | -264.64 | -268.03 | -271.42 | -261.60 | -238.11 | -214.63 | -191.14 | -155.25 | -33.94 | 87.37 | 146.55 | 124.26 | 62.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-69.41 | -52.87 | -60.15 | -54.48 | -66.99 | -68.87 | -51.18 | -27.59 | -41.72 | -68.60 | -98.37 | -132.30 | -131.33 | -142.21 | -153.09 | -163.98 | -167.71 | -175.79 | -183.87 | -191.95 | -194.55 | -205.00 | -215.45 | -225.90 | -218.41 | -201.84 | -185.27 | -168.70 | -181.20 | -197.26 | -213.33 | -161.10 | -136.60 | -68.30 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-203.49 | -138.62 | -201.06 | -181.89 | -207.26 | -202.09 | -113.34 | -59.46 | -91.73 | -87.33 | -85.71 | -90.88 | -84.09 | -88.86 | -95.89 | -98.18 | -96.38 | -91.40 | -84.39 | -81.82 | -81.90 | -82.62 | -84.80 | -83.72 | -73.66 | -69.81 | -64.09 | -59.51 | -23.52 | 11.77 | 39.44 | 52.64 | 30.35 | 12.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | 0.1 | 0.1 | 0.2 | 0.2 | 383.7 | 3592.5 | 3270.6 | 3950.2 | 2009.9 | - | - | - | - | - | - | 22.8 | 58.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | 0.1 | 0.1 | 0.2 | 0.2 | 383.7 | 3592.5 | 3270.6 | 3950.2 | 2009.9 | - | - | - | - | - | - | 22.8 | 58.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | 0.1 | 0.1 | 0.2 | 0.2 | 383.7 | 3592.5 | 3270.6 | 3950.2 | 2009.9 | - | - | - | - | - | - | 22.8 | 58.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD